 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
20/20 GeneSystems Developing mTOR Pathway Test to Predict Herceptin Response in HER2-Positive Patients
September 19, 2012
20/20 GeneSystems Developing mTOR Pathway Test to Predict Herceptin Response in HER2-Positive Patients
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Amplion Research Report Suggests Review Times Longer, Approvals Fewer for MDx over 10 Years
April 17, 2013 / Pharmacogenomics Reporter - Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy
March 13, 2013 / Pharmacogenomics Reporter - CPTAC, Seoul National University to Test Proteomic Workflows Including MRM-MS in Clinical Setting
February 8, 2013 / ProteoMonitor - Boston Children's Mass Spec Study Yields Urine Biomarkers to Diagnose Kawasaki Disease
January 4, 2013 / ProteoMonitor